Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate
May 9th, 2019
11.1K views
Here, a quantitative real-time polymerase chain reaction-based protocol is presented for the determination of the native micro-RNA content (absolute/relative) of lipoprotein particles. In addition, a method for increasing the micro-RNA level, as well as a method for determining the cellular uptake rate of lipoprotein particles, is demonstrated.
Overview
This article presents a quantitative real-time polymerase chain reaction-based protocol for determining the micro-RNA content of lipoprotein particles. It also describes methods for enhancing micro-RNA levels and assessing the cellular uptake rate of these particles.
Key Study Components
Area of Science
- Neuroscience
- Biochemistry
- Molecular Biology
Background
- Lipoprotein particles serve as transport vehicles in biological systems.
- They can be utilized for the delivery of foreign substances.
- Specific labeling allows for the measurement of cellular uptake.
- Methods for enriching lipoprotein particles are adaptable for various substances.
Purpose of Study
- To establish a protocol for quantifying micro-RNA in lipoprotein particles.
- To demonstrate methods for increasing micro-RNA levels.
- To evaluate the cellular uptake of lipoprotein particles.
Methods Used
- Delipidation of HDL particles using a solvent mixture.
- Reconstitution of HDL particles with micro-RNA and spermine.
- Dialysis to recover reconstituted HDL particle solutions.
- High-speed atomic force microscopy for imaging lipoprotein particles.
Main Results
- Successful determination of micro-RNA content in lipoprotein particles.
- Enhanced micro-RNA levels were achieved through the described methods.
- Cellular uptake rates of lipoprotein particles were effectively measured.
Conclusions
- The protocols developed are efficient for studying micro-RNA in lipoprotein particles.
- These methods can be adapted for various research applications.
- Further exploration of lipoprotein particles may enhance understanding of their biological roles.
Frequently Asked Questions
What are lipoprotein particles?
Lipoprotein particles are native transport vehicles that carry lipids and proteins in the bloodstream.
How is micro-RNA content measured in lipoprotein particles?
Micro-RNA content is measured using a quantitative real-time polymerase chain reaction-based protocol.
What methods are used to enhance micro-RNA levels?
The study describes specific reconstitution methods involving micro-RNA and spermine.
What is the significance of cellular uptake measurement?
Measuring cellular uptake helps understand how lipoprotein particles deliver substances into cells.
Can these methods be adapted for other substances?
Yes, the methods for enriching lipoprotein particles can be adapted for a wide range of substances.
What role do lipoprotein particles play in biological systems?
They serve as transport vehicles for lipids and proteins, facilitating cellular communication and metabolism.
Executive Industry Relevance
Quantitative determination of microRNA content in native and enriched lipoprotein particles enables precise assessment of their biological impact in cellular uptake studies. This capability supports mechanistic de-risking and predictive confidence at the interface of target validation and early translational research. Accurate measurement of miRNA transfer rates informs portfolio decisions on delivery vector optimization and functional screening strategies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of miRNA-mediated regulatory pathways via controlled enrichment of lipoprotein carriers.
- Supports functional target validation by quantifying miRNA delivery and cellular uptake.
- Facilitates mechanistic de-risking by distinguishing effects of native versus enriched particles.
Screening & Assay Development
- Provides standardized protocols for preparing miRNA-enriched lipoprotein particles for downstream assays.
- Delivers reproducible, quantitative qPCR and microfluidic array readouts for miRNA content.
- Enables reliable evaluation of cellular uptake rates for screening delivery efficiency.
Translational & Preclinical Research
- Aligns particle uptake and miRNA transfer with disease-relevant cellular models when applicable.
- Supports continuity from in vitro discovery to preclinical validation of delivery vectors.
- Informs risk-adjusted advancement of miRNA-based delivery strategies.
Pipeline & Workflow Integration
This protocol integrates at the transition from early discovery to lead identification, supporting both hypothesis-driven target validation and quantitative screening of delivery vehicles.
- Discovery Biology: Quantifies miRNA loading and transfer to clarify delivery mechanisms and biological effects.
- Screening: Standardizes particle preparation and uptake measurement for comparative analysis.
- Analytics: Provides absolute and relative miRNA quantification via qPCR and microfluidic arrays.
- Translational Research: Enables assessment of delivery efficiency in disease-relevant systems when extended.
- Enterprise Reuse: Offers adaptable protocols for diverse miRNA and particle combinations across programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in miRNA delivery and functional impact.
- Operational Value: Delivers standardized, scalable workflows for particle enrichment and quantification.
- Strategic Value: Improves go/no-go decisions for delivery vector selection and optimization.
- Portfolio Impact: Supports risk-adjusted prioritization of miRNA-based therapeutic strategies.
Implementation Considerations
- Requires expertise in lipoprotein handling, qPCR, and microfluidic array analysis.
- Needs access to high-speed AFM or electron microscopy for particle characterization.
- Demands rigorous RNAse-free technique and cross-team standardization for reproducibility.
- Adaptation may be needed for different particle types or miRNA sequences.
- Particle labeling efficiency and cellular uptake may vary by lipoprotein class and target cell type.
Biopharma FAQs
Why does null hypothesis testing matter for miRNA-enriched particle uptake?
Null hypothesis testing distinguishes whether observed cellular miRNA increases are due to enriched particle delivery or background uptake, supporting robust target validation and mechanistic clarity in delivery studies.
How does independent variable isolation fit the qPCR-based miRNA quantification workflow?
Isolating variables such as particle type and miRNA enrichment ensures that qPCR measurements reflect true differences in delivery efficiency, enabling confident interpretation of functional outcomes.
What do quantitative dependent variable measurements enable in miRNA transfer studies?
Quantitative qPCR and array-based measurements provide absolute and relative miRNA content, allowing teams to compare delivery rates and optimize particle formulations for downstream applications.
Why are replication requirements critical for cross-functional miRNA delivery projects?
Replication ensures that observed miRNA transfer and uptake rates are reproducible across experiments and teams, supporting reliable data for collaborative decision-making and workflow integration.
What statistical analysis capabilities are required before implementing miRNA content assays?
Robust statistical analysis is needed to compare miRNA levels between native and enriched particles, assess significance of cellular uptake changes, and validate assay performance prior to broader implementation.
